PLN-1474 | Interleukin Related interleukin-related.com

Product Name :
PLN-1474

Search keywords :
PLN-1474

drugId :
null

Target Vo:
Integrin alpha-V/beta-1

Target Vo Short Name :
ITGAV&ITGB1

Moa_Name:
Integrin alpha-V/beta-1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Novartis Pharma Ag

Active Company_Name :
Novartis Pharma Ag

Active Indication_Name:
Metabolic Dysfunction-Associated Steatotic Liver Disease

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Tropomyosin alpha 1 Chain Antibody (YA2183) MedChemExpress
Enapotamab Protocol
Atg12 Antibody: Atg12 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 15 kDa, targeting to Atg12. It can be used for WB,IHC-P,ICC assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts